|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 22, No 9 (May 1), 2004: pp. 1756-1758 © 2004 American Society of Clinical Oncology. DOI: 10.1200/JCO.2004.07.088
Germ Cell TumorsCASE 3. Primary Yolk Sac Tumor of the LiverInstitut Gustave Roussy, Villejuif; Hopital Henry Mondor, Creteil; Hopital d'Instruction des Armées, Percy, Clamart, France
A 28-year-old white female presented with a month's history of abdominal pain. She had no previous medical history and was not using oral contraceptives. She reported having lost 3 kg through dieting. She had neither fever nor gastrointestinal symptoms. Physical examination showed abdominal distension and the liver edge was palpable four finger breadths below the right costal margin. She also had bilateral pedal edema. Laboratory tests revealed normal blood cell counts, but abnormal liver function, with elevated AST and ALT two times the normal level and bilirubin three times the normal level. Serum alpha-fetoprotein (AFP) was 54,000 ng/mL, lactate dehydrogenase was 900 U/L (normal is
Hepatoblastoma, hepatocarcinoma, and metastatic yolk sac tumor (YST) were considered in the differential diagnosis. Hepatoblastoma rarely occurs in adults, usually presents as a solid mass, and pathologic examination shows areas of sinusoidal differentiation.1 Hepatocarcinoma predominantly occurs in males, is more common after the age of 50 in Western countries, and usually presents within a cirrhotic liver. However, it can occur in young adults without a background history of chronic hepatitis but is typically a solid mass without a microcystic organization, and has a different immunohistochemical profile with massive antihepatocytic expression and negativity for cytokeratin 7.2
Because postoperative clinical and radiologic assessment showed no evidence of an ovarian or other extrahepatic tumor, the diagnosis of a primary YST of the liver was made. Three weeks after surgery, AFP was 3,600 ng/mL with no evidence of tumor on CT scan. The patient was treated with four cycles of bleomycin, etoposide, and cisplatin chemotherapy.3 AFP returned to 15 ng/mL (normal is Eight patient cases of primary YST of the liver have been reported previously.411 The first report was in 1975.4 Of these eight previously reported patient cases, six involved women with a median age of 27 years (range, 24 to 29 years).510 The histogenesis of primary YST of the liver is unclear. It has been suggested that YSTs might originate from a germ cell that escaped its migration course from the yolk sac to the genital ridge during embryogenesis.4,6 Alternatively the embryonic cell theory favors the persistence of pluripotential embryonic cells that escaped the influence of the differentiation process during embryogenesis in mature liver.7 The clinical behavior of the tumor also is unclear. One patient was reported to have responded to chemotherapy.8 However, all other reported patients died as a result of disease despite the use of an aggressive therapeutic strategy.5,6,9 Our patient responded only moderately to chemotherapy. The clinical behavior of this tumor seemed similar to that of a hepatoid ovarian YST, which also is of germ cell origin. To our knowledge, the similarity between these two types of rare YST, both arising in a young women, has never before been addressed. In conclusion, better characterization of the biologic and pathologic features of this tumor is still needed as well as knowledge of its clinical behavior. This would justify registration in a rare tumor registry and a centralized pathological review. Authors' Disclosures of Potential Conflicts of Interest The authors indicated no potential conflicts of interest.
REFERENCES 1. Vicente D, Bernabe R, Mazo J, et al: Hepatoblastoma in an adult. Med Clin (Barc) 116:758, 2001 2. Wittekind C: Pathology of liver tumors. Zentralbl Chir 125:587591, 2000[Medline] 3. Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ cell tumors with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 316:14351440, 1987[Abstract] 4. Hart WR: Primary endodermal sinus (yolk sac) tumor of the liver: First reported case. Cancer 35:14531458, 1975[CrossRef][Medline] 5. Narita T, Moriyama Y, Ito Y: Endodermal sinus (yolk sac) tumor of the liver: A case report and review of the literature. J Pathol 155:4147, 1988[Medline] 6. Natori T, Teshima S, Kikuchi Y, et al: Primary yolk sac tumor of the liver, an autopsy case with ultra structural and immunohistochemical studies. Acta Pathol Jpn 33:555564, 1983[Medline] 7. Villaschi S, Balistreri P: Endodermal sinus tumor of the liver. Histopathology 18:8688, 1991[Medline] 8. Wheelan JS, Stebbings W, Owen RA, et al: Successful treatment of primary endodermal sinus tumor of the liver. Cancer 70:22602262, 1992[Medline] 9. Higuichi T, Kikuchi M: Yolk sac tumor of the liver treated with trans-catheter arterial embolization. Am J Gastroenterol 88:11251126, 1993[Medline] 10. Wong NA, D'Costa H, Barry RE, et al: Primary yolk sac tumor of the liver in adulthood. J Clin Pathol 51:939940, 1998[Abstract] 11. Devouassoux-Shisheboran M, Schammel DP, Tavassoli FA: Ovarian hepatoid yolk sac tumours: Morphological, immunohistochemical and ultrastructural features. Histopathology 34:462469, 1999[Medline]
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2004 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|